| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 71,914 | 63,056 | 59,129 | 58,004 |
| Cost of revenue | 30,569 | 26,325 | 25,850 | 23,633 |
| Gross profit | 41,345 | 36,731 | 33,279 | 34,371 |
| Selling, general and administrative | 31,919 | 28,803 | 28,425 | 26,671 |
| Research and development | 775 | 847 | 797 | 757 |
| Stock-based compensation | 2,180 | 2,341 | 2,311 | 1,712 |
| Depreciation and amortization | 397 | 353 | 348 | 348 |
| Loss (gain) on disposal of property and equipment | -476 | 636 | 2,368 | 469 |
| Other expense (income), net | 44 | 72 | 75 | 276 |
| Income from operations | 5,642 | 5,095 | 3,841 | 5,628 |
| Income (loss) from investments | 0 | 0 | - | 96 |
| Interest expense, net | -507 | -132 | -179 | -225 |
| Net income before taxes | 5,135 | 4,963 | 3,662 | 5,499 |
| Provision for income taxes | 1,535 | 1,713 | 952 | 1,594 |
| Net income | 3,600 | 3,250 | 2,710 | 3,905 |
| Net income attributable to noncontrolling interest | 87 | 93 | 85 | 27 |
| Net income attributable to viemed healthcare, inc | 3,513 | 3,157 | 2,625 | 3,878 |
| Basic (in shares) | 38,638,660 | 39,515,247 | 39,426,753 | 38,870,823 |
| Basic (in usd per share) | 0.09 | 0.08 | 0.07 | 0.1 |
| Diluted (in shares) | 40,495,761 | 41,083,760 | 41,627,876 | 40,779,414 |
| Diluted (in usd per share) | 0.09 | 0.08 | 0.06 | 0.1 |
VIEMED HEALTHCARE, INC. (VMD)
VIEMED HEALTHCARE, INC. (VMD)